Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapy

J Med Virol. 2006 Jul;78(7):906-10. doi: 10.1002/jmv.20639.

Abstract

Although hepatitis B virus (HBV) precore-stop mutant (nonsense mutation at codon 28) is usually isolated from patients with hepatitis B e antigen (HBeAg)-negative hepatitis, it is unclear whether the mutant is the cause of the hepatitis flare or it is a consequence of necroinflammation. Using the amplification-created restriction site method, the ratios of precore-stop mutant were measured in serial serum samples obtained from three patients experiencing HBeAg-negative hepatitis after withdrawal of lamivudine therapy. In all three patients, the precore-stop mutant emerged and took over the viral population at least 2 months prior to the hepatitis exacerbations. After the onset of exacerbation, transient elevation of serum HBV-DNA was observed, which was followed by progressive decrease of the ratio of precore-stop mutant as well as normalization of serum transaminases. The present data indicate that at least in some patients, the precore-stop mutant is the cause but not the consequence of the flare of HBeAg-negative hepatitis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Base Sequence
  • Codon, Nonsense*
  • DNA, Viral / blood
  • DNA, Viral / genetics
  • Female
  • Genes, Viral
  • Hepatitis B e Antigens / blood
  • Hepatitis B e Antigens / genetics*
  • Hepatitis B virus / genetics*
  • Hepatitis B virus / immunology
  • Hepatitis B, Chronic / drug therapy
  • Hepatitis B, Chronic / virology*
  • Humans
  • Lamivudine / administration & dosage
  • Lamivudine / therapeutic use
  • Male
  • Middle Aged
  • Promoter Regions, Genetic

Substances

  • Antiviral Agents
  • Codon, Nonsense
  • DNA, Viral
  • Hepatitis B e Antigens
  • Lamivudine